The retest date and the expiry date are not the same document
We asked twenty companies three questions about stability data and print every answer, refusal and non-response.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Stability
Reversed-phase chromatography runs in an organic, acidic mobile phase that dissociates most non-covalent aggregates on the way to the detector.
The single most consequential fact about deamidation is that the isoaspartate product has the same molecular weight as the parent peptide, because the rearrangement moves an atom rather than adding or removing one. A laboratory confirming identity by molecular ion mass alone will report a substantially deamidated preparation as the intended compound. Separation is possible — the isomers usually resolve on a sufficiently shallow reversed-phase gradient, and specialist methods resolve them reliably — but only if the method was designed to look. A twelve-minute generic gradient does not look.
Deamidation of asparagine proceeds through nucleophilic attack by the backbone nitrogen of the following residue on the asparagine side-chain carbonyl, forming a five-membered succinimide intermediate which then hydrolyses to a mixture of aspartate and isoaspartate, conventionally in a ratio favouring the isomer roughly three to one. Glutamine deamidates by an analogous route, far more slowly, through a six-membered intermediate.
Three factors govern the rate. Sequence is dominant: the residue immediately following the asparagine determines how readily the intermediate forms, and asparagine-glycine is the fastest motif known, with serine, histidine and alanine following. Solution pH matters, with the rate minimal in the mildly acidic region and rising steeply above neutrality as the backbone nitrogen becomes more nucleophilic. Temperature and water activity set the overall pace, which is why the solid state helps so much.
The analytical problem is that isoaspartate has the same elemental composition and therefore the same molecular mass as the parent. Identity confirmation by molecular ion alone cannot distinguish them, and a preparation that is substantially deamidated will present as the intended compound. The isomers usually separate on a sufficiently shallow reversed-phase gradient, and specific methods exist, but only a method designed for the question will find the answer.1
Methionine oxidises to the sulfoxide and, under harsher conditions, the sulfone. Tryptophan oxidises through a series of products including kynurenine derivatives. Histidine and tyrosine are susceptible under metal-catalysed conditions, and free cysteine oxidises readily to disulphide. Each of these products differs from the parent by a defined mass increment, which makes oxidation the pathway most reliably detected by mass spectrometry: the sulfoxide is sixteen mass units heavier and unmistakable.
The interesting question is usually where the oxidant came from, and the answers are mundane. Trace transition metals leached from glass, stainless steel or a stopper catalyse oxidation of several residues. Peroxides accumulate in polysorbate surfactants during storage and are a well-documented source of methionine oxidation in formulated products. Dissolved oxygen in the diluent contributes. Light drives it, particularly for tryptophan, and light exposure during handling is entirely undocumented in this trade.
Practical consequences follow that are not obvious. A formulation containing a surfactant that has itself been stored warm for a year may oxidise a peptide that would have been perfectly stable in a plain aqueous vehicle. Headspace composition matters: vials backfilled with nitrogen behave differently from vials sealed under air, and the difference is a manufacturing choice recorded nowhere on the label.2
The aggregate arrives at the column, comes apart, and is recorded as monomer.
Callum Brathwaite, Analytical Chemistry CorrespondentA stability study is only as good as the analytical method behind it, and the requirement has a name: the method must be stability-indicating, meaning it must resolve the parent compound from its degradation products and quantify the change. Establishing that is done by forced degradation — deliberately stressing the material with acid, base, oxidant, heat and light — and demonstrating that the resulting products are separated from the parent and from each other with adequate peak purity.
Almost nothing sold as a purity determination in this market has been validated that way. A generic peptide gradient run for twelve minutes may perfectly well resolve the parent from its two largest process impurities and entirely fail to resolve it from its isoaspartate isomer or a closely related oxidation product. The number it returns is a purity figure, not a stability measurement, and using a series of such figures to argue that a product has not degraded is a category error.
The compendial guidance on analytical validation is explicit about specificity, and about demonstrating it against the degradation products the molecule can actually form. The gap between that expectation and practice in this trade is not a matter of dishonesty. It is that the method being sold was designed for a different purpose and is being asked a question it was not built to answer.3
A single-use indicator records that a threshold was crossed and not for how long. Ten minutes on a loading bay and eleven hours in a hot van produce the same mark, which is why an indicator is a prompt to ask a question rather than an answer to one.
| Intended storage | Long-term condition | Intermediate | Accelerated |
|---|---|---|---|
| Room temperature | 25 °C / 60% RH, ≥12 months | 30 °C / 65% RH | 40 °C / 75% RH, 6 months |
| Room temperature, hot climatic zone | 30 °C / 65% RH, ≥12 months | not applicable | 40 °C / 75% RH, 6 months |
| Refrigerated | 5 °C ± 3 °C, ≥12 months | not applicable | 25 °C / 60% RH, 6 months |
| Frozen | −20 °C ± 5 °C, ≥12 months | not applicable | single-batch excursion study |
| Below −20 °C | case by case | not applicable | single-batch excursion study |
| Summarised from the harmonised guideline on stability testing of new drug substances and products. Frozen-storage products are not accelerated in the usual sense; the guidance substitutes a study of the effect of a short excursion above the intended condition, which is precisely the data a shipped research vial would need and does not have. | |||
The temptation with any stability programme is to run the accelerated condition, fit an Arrhenius relationship to the rate constants, and extrapolate to the intended storage temperature. For a single reaction with a temperature-independent mechanism that is sound. For peptides it frequently is not, and the reason is that different pathways have different activation energies.
Suppose a peptide degrades at five degrees principally by deamidation and at forty degrees principally by hydrolysis, with the second having a higher activation energy. Measuring total degradation at forty degrees measures mostly hydrolysis; extrapolating that rate down to five degrees predicts almost nothing about the deamidation that will actually dominate. Aggregation is worse still, because it is frequently nucleated by interfaces and mechanical stress rather than by thermal energy alone, and does not obey a simple temperature relationship at all.
The practical rule the Journal applies when reading a stability claim is to ask what condition the data was generated at and whether the degradation products were identified as well as quantified. Accelerated data that shows which products form is genuinely useful as a warning of what to watch for. Accelerated data reduced to a single percentage and extrapolated to a shelf life is a projection dressed as a measurement, and for this class of molecule it is a poor projection.
Photostability has its own guideline, its own defined light source options and its own exposure requirement expressed in lux hours of visible light and watt hours per square metre of near ultraviolet. Products are tested in the immediate container, and where they fail, in the marketing pack, and where they fail again the label carries a protection instruction. The chemistry is real: tryptophan and tyrosine absorb in the near ultraviolet and photo-oxidise, and photolytic disulphide cleavage is well documented.
Nothing about light exposure is recorded anywhere in the research-peptide supply chain. Vials are frequently supplied in clear glass. Photographs for listings are taken under studio lighting. Parcels are opened on kitchen counters. A reconstituted vial may sit on a shelf under a window for weeks. The cumulative exposure is unknown and unknowable, and it is plausibly a larger contributor to degradation than the transit excursions that attract all the attention.
The Journal makes one narrow observation rather than a recommendation, because recommendations are not this publication’s business. Amber glass, or a secondary carton, costs a fraction of a cent per unit and removes an uncontrolled variable entirely. Several of the twenty companies we track ship in amber vials as standard, and the remainder will supply amber on request at no extra charge, which is the answer a buyer who cares about photostability should ask for.4
Mean kinetic temperature is a legitimate tool for a whole storage period and is routinely misapplied to a single shipment, where it is used to argue that a two-day excursion averaged out. The arithmetic is sound; the frame is not.
The customs leg remains the part of this story we cannot report properly, and it deserves saying every time the subject comes up: there is a segment of every cross-border journey during which nobody measures and nobody has authority to intervene. Any claim of end-to-end control across that segment is a claim about something unobserved.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
The pathways that matter for potency and the pathways that matter for immunogenicity are not the same set, and only the first is discussed in this market at all. The second is a proper research question and not a topic for speculation.
— D. Ramkissoon, Port of Spain
Oxidation of methionine is fast, common and detectable, and the mass shift is small enough that a low-resolution instrument will miss it. It is a good example of a pathway that is easy to find if you look for it and easy to miss otherwise.
— M. Sandhu, Amritsar
Your section on freezing reconstituted solution stops short of the obvious question, which I will therefore ask. If a phosphate buffer shifts pH substantially on freezing, does that not mean the freezer is actively worse than the refrigerator for a buffered formulation, rather than merely unproven?
— C. Rautenbach, Pretoria
For a phosphate-buffered formulation, plausibly yes, and the mechanism is well documented. We stopped short because the magnitude is formulation-specific and because most reconstituted research vials are in unbuffered water or bacteriostatic water, where the argument is about the interface rather than about pH. We should have made that distinction in the text instead of leaving a gap for you to find.
We asked twenty companies three questions about stability data and print every answer, refusal and non-response.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
The supplier confirmed the determination and supplied the method behind its own figure inside a week.